SAN FRANCISCO & HOUSTON--(BUSINESS WIRE)--Tachyon Therapeutics, Inc. ("Tachyon" or "the Company"), a private, clinical-stage biotechnology company developing transformative cancer therapies against ...
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T ...
BERKELEY, Calif., April 24, 2025--(BUSINESS WIRE)--Ray Therapeutics, a biotechnology company developing optogenetic gene therapies for vision restoration, today announced it has been awarded an $8 ...
After funding stem cell research since 2004, the California Institute for Regenerative Medicine is running out of funds. The state agency currently has funding requests for $88 million pending but ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T-cell therapies to treat cancer, today announced that the California Institute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback